Abstract:Objective: To explore the clinical significance of the detection of PTH and Hcy in patients with the chronic kidney disease. Methods: 48 patients with chronic kidney disease (CKD) were divided into three groups: CKD stage 3, CKD stage 4 and CKD stage 5 according to the clinical diagnosis. PTH, Cys C, Hcy and Cr were detected in three groups, and the statistical analysis was conducted. Results: The levels of serum PTH, Cys C, Hcy and Cr in CKD stage 5 group were higher than those in CKD stage 4 and CKD stage 3 groups, the difference was statistically significant (P<0.05), but there was no significant difference between CKD stage 4 group and CKD stage 3 group in serum PTH, Cys C , Hcy and Cr levels (P>0.05 ). The positive rates of PTH in CKD stage 5 group, CKD stage 4 group and CKD stage 3 group were: 70.8%, 21.4%, 20%; The positive rates of Hcy in CKD stage 5 group, CKD stage 4 group and CKD stage 3 group were: 58.3%, 7.1%, 10% . PTH,Hcy,Cr and Cys C were positively correlated(R=0.505、0.855、0.788). Conclusion: The combined detection of PTH, Hcy and other indicators is helpful for the diagnosis and judgment of CKD patients, and provides accurate guidance for clinical diagnosis and treatment.
刘虹, 金娟, 周志凤, 张白银, 郑元杰, 陈正徐, 曹娟. 慢性肾脏病患者甲状旁腺激素同型半胱氨酸检测的临床意义[J]. 河北医学, 2019, 25(3): 577-579.
LIU Hong, JIN Juan, ZHOU Zhifeng, et al. Clinical Significance of Detection of Parathyroid Hormone and Homocysteine in Patients with Chronic Kidney Disease. HeBei Med, 2019, 25(3): 577-579.
[1] 王敏,顾洁,曹华.肾功能指标对慢性肾病的预测价值研究[J].国际检验医学杂志,2014,35(22):3034~3035. [2] 刘莉华,秦淑国,马胜银,等.血清同型半胱氨酸胱抑素维生素B6及炎症因子在糖尿病肾脏病中的临床意义[J].安徽医学,2018,39(3):278~281. [3] National Kidney Foundation.K/DOQI clinical practice guidelines for chronic kidney disease:evaluation,classification,and stratification[J].Am Kidney Dis,2002,39(2 Suppl 1):S1~266. [4] 李锦芬,李晓忠.血清胱抑素C纤维蛋白原及24h尿蛋白定量对紫癜性肾炎儿童肾损伤程度的评估效果[J].安徽医学,2018,39(2):186~188. [5] Ix JH, Anderson CA, Smits G, Persky MS, Block GA. Effect of dietary phosphate intake on the circadian rhythm of serum phosphate concentrations in chronic kidney disease: a crossover study[J]. The American Journal of Clinical Nutrition,2014,100(5):1392~1397. [6] 龙林会,张德文,陈芳.慢性肾功能衰竭患者血清甲状旁腺激素与胱抑素C及同型半胱氨酸的相关性研究[J].现代医药卫生,2015,31(5):673~675. [7] Jakovljevic B, Gasic B, Kovacevic P, et al.Homocystein as a risk factor for developing complications in chronic renal failure [J].Mater Sociomed, 2015 ,27(2):95~98.